HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (87) Citing Articles via Google Scholar Google Scholar Articles by Ockene, J K Articles by Meilahn, E Search for Related Content PubMed PubMed Citation Articles by Ockene, J K Articles by Meilahn, E

The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT).

J K Ockene, L H Kuller, K H Svendsen and E Meilahn

Department of Medicine, University of Massachusetts Medical School, Worcester 01655.

The impact of smoking cessation on coronary heart disease (CHD) and lung cancer was assessed after 10.5 years of follow-up in the 12,866 men in the Multiple Risk Factor Intervention Trial (MRFIT). Those men who died of lung cancer (n = 119) were either cigarette smokers at entry or ex-smokers; no lung cancer deaths occurred among the 1,859 men who reported never smoking cigarettes. The risk of lung cancer for smokers, adjusted for selected baseline variables using a Cox proportional hazards model, increased as the number of cigarettes smoked increased (B = 0.0203, SE = 0.0076). There was not the same graded response for CHD among smokers at entry. The risk of CHD death was greater among smokers than nonsmokers (RR = 1.57) (B = -0.0034, S.E. = 0.0048). After one year of cessation, the relative risk of dying of CHD for the quitters as compared to non-quitters (RR = 0.63) was significantly lower even after adjusting for baseline differences and changes in other risk factors. The relative risk for smokers who quit for at least the first three years of the trial was even lower compared to non-quitters (RR = 0.38). However, the relative risk for lung cancer for quitters versus non-quitters was close to 1 both for quitters at 12 months and at three years. These data support the benefits of cessation in relation to CHD and are consistent with other epidemiologic studies which suggest that the lag time for a beneficial effect of smoking cessation on lung cancer may be as long as 20 years.

This article has been cited by other articles:

				D V Joseph, J A Jackson, J Westaway, N A Taub, S A Petersen, and M P Wailoo Effect of parental smoking on cotinine levels in newborns Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2007; 92(6): F484 - F488. [Abstract] [Full Text] [PDF]

				M. Rosen Chapter 5.1: Major public health problems -- cardiovascular diseases Scand J Public Health, June 1, 2006; 34(67_suppl): 51 - 58. [PDF]

				J. T. van Wyk, M. A.M. van Wijk, M. C.J.M. Sturkenboom, P. W. Moorman, and J. van der Lei Identification of the Four Conventional Cardiovascular Disease Risk Factors by Dutch General Practitioners Chest, October 1, 2005; 128(4): 2521 - 2527. [Abstract] [Full Text] [PDF]

				J. E Harris, M. J Thun, A. M Mondul, and E. E Calle Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8 BMJ, January 10, 2004; 328(7431): 72. [Abstract] [Full Text] [PDF]

				M. GLICK Screening for traditional risk factors for cardiovascular disease: A review for oral health care providers J Am Dent Assoc, March 1, 2002; 133(3): 291 - 300. [Abstract] [Full Text] [PDF]

				S. Shea, J. Starren, R. S. Weinstock, P. E. Knudson, J. Teresi, D. Holmes, W. Palmas, L. Field, R. Goland, C. Tuck, et al. Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: Rationale and Design J. Am. Med. Inform. Assoc., January 1, 2002; 9(1): 49 - 62. [Abstract] [Full Text] [PDF]

				S. A. Khuder and A. B. Mutgi Effect of Smoking Cessation on Major Histologic Types of Lung Cancer Chest, November 1, 2001; 120(5): 1577 - 1583. [Abstract] [Full Text] [PDF]

				H. J. Milionis, E. Rizos, and D. P. Mikhailidis Smoking Diminishes the Beneficial Effect of Statins: Observations from the Landmark Trials Angiology, September 1, 2001; 52(9): 575 - 587. [Abstract] [PDF]

				Q Qiao, M Tervahauta, A Nissinen, and J Tuomilehto Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men Eur. Heart J., October 1, 2000; 21(19): 1621 - 1626. [Abstract] [PDF]

				B. L. KASISKE and D. KLINGER Cigarette Smoking in Renal Transplant Recipients J. Am. Soc. Nephrol., April 1, 2000; 11(4): 753 - 759. [Abstract] [Full Text] [PDF]

				S. M. Grundy Primary Prevention of Coronary Heart Disease : Integrating Risk Assessment With Intervention Circulation, August 31, 1999; 100(9): 988 - 998. [Full Text] [PDF]